AVXL

AVXL Stock-Based Compensation

-$11.94MTTM · USD

Period ending:

AVXL FY Stock-Based CompUSD
AVXL FY Stock-Based Comp2004-09-30: $0.002005-09-30: $0.002006-09-30: $0.002007-09-30: $0.002008-09-30: $0.002009-09-30: $812.34K2010-09-30: $770.06K2011-09-30: $1.27M2012-09-30: $302.21K2013-09-30: $1.00M2014-09-30: $637.93K2015-09-30: $1.63M2016-09-30: $5.06M2017-09-30: $4.14M2018-09-30: $5.52M2019-09-30: $6.43M2020-09-30: $4.88M2021-09-30: $8.23M2022-09-30: $18.38M2023-09-30: $16.37M2024-09-30: $9.44M2025-09-30: $11.55M$18.38M$0.00
2004-09-302025-09-30

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

AVXL stock-based compensation history

Non-cash compensation expense paid in equity. The available annual fiscal periods series contains 22 observations from Sep 30, 2004 to Sep 30, 2025.

Anavex Life Sciences Corp Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
11,549,000
9,438,000
16,370,000
18,379,000
8,231,000
4,876,906
6,430,873
5,517,004
4,135,570
5,062,267
1,633,979
637,925
1,002,500
302,208
1,273,162
770,055
812,336
0
0
0
0
0

Compare stock-based compensation

All AVXL financial metrics · AVXL stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.